KV1.7 activators refer to a class of chemical compounds that selectively bind to and modulate the activity of the KV1.7 potassium channel, a type of voltage-gated potassium channel (VGKC). These channels are integral membrane proteins that facilitate the selective flow of potassium ions across the cell membrane, which is crucial for maintaining the membrane potential and regulating cellular excitability. KV1.7 channels, like other family members, consist of four subunits that come together to form a pore through which potassium ions can pass in response to changes in the electrical potential across the cell membrane. Activators of KV1.7 channels are distinguished by their ability to increase the channel's open-probability or shift its voltage-dependence of activation, thereby enhancing the potassium current through these channels under conditions where they would normally be less active or inactive.
The action of KV1.7 activators at the molecular level involves specific interactions with the channel protein that lead to alterations in its conformational state, promoting the opening of the channel pore. These interactions may stabilize the open state or destabilize the closed state of the channel, depending on the binding site and the nature of the activator. The chemical structures of KV1.7 activators are diverse, and their design is often informed by the detailed structural and functional characteristics of the KV1.7 channel. The chemical complexity of these activators is reflected in their specificity and selectivity for the KV1.7 channel, as they must discriminate this particular channel subtype from other closely related VGKCs. Effective activators typically exhibit a high affinity for KV1.7, ensuring that they can modulate the channel's activity at relatively low concentrations, and their binding is often reversible, allowing for a controlled modulation of channel activity. The development of these compounds involves sophisticated techniques in chemistry, computational modeling, and electrophysiological testing to fine-tune their interactions with the channel and to maximize their selectivity and potency.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin can elevate cAMP, which may enhance KCNA7 transcription through cAMP response element-binding protein. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression, potentially increasing the transcription of KCNA7. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA may activate protein kinase C, leading to transcriptional changes that could include upregulation of KCNA7. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
This demethylating agent may upregulate KCNA7 by reversing methylation-silenced gene expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As a histone deacetylase inhibitor, it could promote KCNA7 expression by increasing histone acetylation. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium might influence GSK-3 activity, leading to transcriptional changes that could upregulate KCNA7. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
It might interact with estrogen receptors, potentially increasing KCNA7 gene transcription. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
It may activate glucocorticoid receptors, which could influence KCNA7 gene expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane might activate various transcription factors, possibly leading to an increase in KCNA7 expression. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibition of mTOR by rapamycin might affect transcriptional regulation, potentially increasing KCNA7 expression. | ||||||